CA10

Across TCGA pan-cancer cohorts, CA10 Mutation is linked to patient survival in 5 of 34 cancer types, making it a survival-associated CA10 data layer compared with 19 for mass-spec protein.

The strongest signal is observed in lung adenocarcinoma (LUAD), where higher CA10 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated CA10 expression acts as an unfavorable survival marker.

LUAD, KIRC, and OV are the cancer types where CA10 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUAD	OS	Median	II,III,IV	0.251	0.754	<.001	24	view →
KIRC	OS	Median	All	0.170	0.811	.001	18	view →
OV	OS	Median	All	0.590	0.842	.012	12	view →
LUSC	OS	Median	II,III,IV	0.212	0.735	.002	6	view →
SKCM	DFS	Median	All	0.117	0.218	.017	6	view →

Pink = unfavorable, green = favorable. Showing the 5 strongest of 5 lineages.

CA10–LUAD (OS)

Open the LUAD breakdown →